Key facts
- Quantum Surgical’s last known valuation is $17.6M (Jun 2018).
- It has raised $90.8M across 1 recorded rounds; the latest was Later Stage VC ($75.0M) in Aug 2025.
- Notable investors include Bpifrance, Ally Bridge Group, Caisse d'Epargne, Languedoc-Roussillon Region, Muhan Investment Company.
- Quantum Surgical has filed 2 Form Ds with the SEC, most recently Sep 2025 ($75.0M sold to 26 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Quantum Surgical
Funding rounds
1 roundsAbout Quantum Surgical
Developer of surgical robotics designed to offer intelligent tools for minimally invasive surgeries. The company's robotics helps in advanced percutaneous ablation therapy for liver cancer treatment, enabling healthcare providers to cure their patients, improve lives, and get benefits from safer interventional oncology procedures.
- Sector
- Healthcare
- HQ
- Montpellier, France
- Founded
- 2016
- Employees
- 140
- Website
- quantumsurgical.com/
- Ownership
- Privately Held (backing)
Quantum Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Quantum Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Quantum Surgical in its N-PORT filings yet. We sweep new filings monthly.